New York, NY -- (SBWIRE) -- 10/05/2013 -- StockMarketIntel.com issues a special report on the following stocks: NewLead Holdings Ltd(NASDAQ:NEWL), Molycorp Inc(NYSE:MCP), Pfizer Inc.(NYSE:PFE),Sarepta Therapeutics Inc(NASDAQ:SRPT)
NewLead Holdings Ltd(NASDAQ:NEWL) managed to keep its fall at -8.51% on below -normal volume of 7.63M shares. The stock settled at $0.105 after floating in a range of $0.10 to $0.12. Its latest price has reached market capitalization of $41.81 million. Its 52-week range has been $0.07 to $2.73. NewLead Holdings Ltd. (NewLead) is an international shipping company engaged in the transportation of refined products, such as gasoline and jet fuel, and dry bulk goods, such as iron ore, coal and grain.
Can Investors Bet on NEWL after this News update? Find out in this Research Report
Molycorp Inc(NYSE:MCP) traded up on a volume of 6.53million, higher than its standard daily volume. Shares have gained 1.81% to $7.32. Over the last twelve months, the stock has lost -36.35% and faced a worst price of $4.70. Molycorp, Inc. provides Rare Earths and Molybdenum products to companies. The Company's rare earth products comprise of bastnasite, cerium, europium, lanthanum, neodymium, praseodymium, yttrium, and other lanthanides.
Is MCP a Solid Investment at These Levels? Read This Report For Details
Pfizer Inc.(NYSE:PFE) settled +0.80% higher at $29.00 on below -normal volume of 19.54M shares during the last trading day. The stock has its 12-month high at $31.15 and 52-week low price was $23.55. It traded in a range of $28.60 to $29.04 during the last trading day. Pfizer Inc. (Pfizer) is a research-based, global biopharmaceutical company. The Company manages its operations through five segments: Primary Care; Specialty Care and Oncology; Established Products and Emerging Markets; Animal Health and Consumer Healthcare, and Nutrition.
How Should Investors Trade PFE Now? Don’t Miss out a Special Trend Analysis
In the last trading session, Sarepta Therapeutics Inc (NASDAQ:SRPT) was up on high volume, trading at a volume of 3.29M versus its average daily volume of 1.93 million shares. At $53.48, the stock has attained market capitalization of 1.79 billion. Sarepta Therapeutics Inc., formerly AVI BioPharma, Inc., biopharmaceutical company focused on the discovery and development of ribonucleic acid (RNA)-based therapeutics for the treatment of rare and infectious diseases
What SRPT’s Charts Are Signaling for Traders? Find Out Here
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.html
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)